3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Melanoma
5
Colitis
4
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Vasculitis
1
Stroke
1
Skin Neoplasms
1
Lung Neoplasms
1
Kidney Transplantation
1
Hepatitis
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Drug-Related Side Effects and Adverse Reactions
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Colitis, Ulcerative
1
Bronchiolitis Obliterans Syndrome
1
Bipolar Disorder
1
Aneurysm
1
Interventions
Saline Solution
1
Infliximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Depressive Disorder, Treatment-Resistant
×
Infliximab
×
1 year
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts